… but saruplase had a higher occurrence of hemorrhagic strokes [29]. … investigators G. A
comparison of reteplase with … Role of intracoronary fibrinolytic therapy in contemporary PCI …

… It is aptly called by WHO as the modern epidemic. The … of plasminogen activator and also
plasminogen activator … risk of bleeding that contraindicates use of fibrinolytic therapy (Class IIa). …

… reported in our study than in the GUSTO-I trial. Median systolic blood … Investigators of the
International Tissue Plasminogen … Incidence and predictors of bleeding after contemporary …

… myocardial infarction. Although the rapid administration of … Some investigators have
wondered whether unsuccessful … Contemporary reperfusion therapy for cardiogenic shock: the …

… By modern standards, these trials had major design flaws. … hemorrhage after thrombolytic
therapy, regardless of the … between streptokinase and tissue plasminogen activator, as the …

… Incidence and predictors of bleeding after contemporary … lytic (ASSENT-2) Investigators.
Single-bolus tenecteplase … TNK-tissue plasminogen activator in acute myocardial infarction (TIMI …

… the risk of hemorrhagic stroke induced by thrombolytic therapy, … In one trial, the investigators
were able to compare … Acute myocardial infarction: contemporary risk and management …

… Researchers invented numerous potent fibrinolytic agents … for accelerated tissue plasminogen
activator when compared … sloughing rather than an active bleeding, fibrinolytic therapy is …

… hemorrhage (ICH), particularly in older patients (3). … a lower incidence of left anterior
descending coronary artery infarct (… arteries (GUSTO) V-AMI study, comparing standard fibrinolysis …

… Arteries (GUSTO III) Investigators. A comparison of reteplase with … Incidence and predictors
of bleeding after contemporary … Global Utilization of Streptokinase and Tissue Plasminogen …